Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 5:36 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 626,862 9.990% | 61,378 (+10.85%) | View |
| 2024-06-18 4:30 pm Unchanged | 13D | AYTU BIOPHARMA INC AYTU | Nantahala Capital Management LLC | 1,086,812 18.200% | 0 (Unchanged) | View |
| 2024-02-13 4:25 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 565,484 9.990% | 1,642 (+0.29%) | View |
| 2023-06-16 5:14 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | Nantahala Capital Management LLC | 1,086,812 19.700% | 815,217 (+300.16%) | View |
| 2023-06-16 4:48 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 563,842 9.990% | 563,842 (New Position) | View |
| 2023-05-26 1:52 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | Nantahala Capital Management LLC | 271,595 7.200% | 271,595 (New Position) | View |
| 2023-02-14 11:23 am Purchase | 13G | AYTU BIOPHARMA INC AYTU | CVI Investments Inc. | 3,278,844 4.900% | 3,278,844 (New Position) | View |
| 2022-08-15 10:01 am Purchase | 13G | AYTU BIOPHARMA INC AYTU | CVI Investments Inc. | 3,400,000 5.600% | 3,400,000 (New Position) | View |
| 2022-02-11 3:29 pm Sale | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 0 0.000% | -1,398,776 (Position Closed) | View |
| 2021-09-01 4:25 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | ARMISTICE CAPITAL LLC | 1,376,545 4.900% | 34,167 (+2.55%) | View |
| 2021-08-31 4:32 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | ARMISTICE CAPITAL LLC | 1,342,378 5.300% | 1,342,378 (New Position) | View |
| 2021-03-26 4:21 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | INTEGRATED CORE STRATEGIES (US) LLC | 22,866 0.100% | 22,866 (New Position) | View |
| 2021-02-12 4:57 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 1,398,776 8.100% | 65,442 (+4.91%) | View |
| 2021-02-10 10:45 am Unchanged | 13G | AYTU BIOPHARMA INC AYTU | Altium Capital Management LP | 0 0.000% | 0 (Unchanged) | View |
| 2021-01-05 11:45 am Purchase | 13G | AYTU BIOPHARMA INC AYTU | SABBY MANAGEMENT LLC | 730,707 11.000% | 730,707 (New Position) | View |
| 2020-12-21 5:07 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | ARMISTICE CAPITAL LLC | 1,333,334 7.700% | 925,961 (+227.30%) | View |
| 2020-12-16 6:02 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 1,333,334 7.700% | 1,333,334 (New Position) | View |
| 2020-04-29 5:29 pm Sale | 13D | AYTU BIOPHARMA INC AYTU | ARMISTICE CAPITAL LLC | 407,373 0.400% | -4,701,548 (-92.03%) | View |
| 2020-04-27 4:30 pm Unchanged | 13G | AYTU BIOPHARMA INC AYTU | Avalo Therapeutics Inc. AVTX | 0 0.000% | 0 (Unchanged) | View |
| 2020-04-08 4:21 pm Purchase | 13D | AYTU BIOPHARMA INC AYTU | ARMISTICE CAPITAL LLC | 5,108,921 5.300% | 108,920 (+2.18%) | View |